Contineum Therapeutics, Inc. Class A Common StockCTNMNASDAQ
Loading
Debt to Assets Over TimeCompressed
Percentile Rank25
3Y CAGR-36.3%
Studio
Year-over-Year Change

Debt-to-assets ratio

3Y CAGR
-36.3%/yr
Annual compound
Percentile
P25
Within normal range
vs 3Y Ago
0.3x
Contraction
Streak
1 yr
Consecutive growthCompressed
PeriodValueYoY Change
20250.03+1.4%
20240.03-98.0%
20231.48+1182.7%
20220.12+65.9%
20210.07-